ESTA · Establishment Labs Holdings Inc.
$79.47
+3.88 (+5.13%)
At close · Aug 14
Market Cap
$2.37B
Shares
29.80M
Establishment Labs Holdings Inc. Earnings Call Transcripts
Every quarterly earnings call for Establishment Labs Holdings Inc. (ESTA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲31.7%
$38.24M
−$18.61M
'22 Q3
22-11-07
▲24.1%
$43.81M
−$13.56M
'22 Q4
23-02-27
▲21%
$46.52M
−$11.94M
'23 Q1
23-05-08
▲17.9%
$48.56M
−$16.75M
'23 Q2
23-08-08
▲0.7%
$38.51M
−$29.27M
'23 Q3
23-11-07
▼28%
$31.56M
−$20.54M
'23 Q4
24-02-28
▼20.1%
$37.17M
−$16.20M
'24 Q1
24-05-08
▼9.2%
$44.12M
−$17.18M
'24 Q2
24-08-06
▲4.5%
$40.23M
−$16.68M
'24 Q3
24-11-07
▲41%
$44.51M
−$34.53M
'24 Q4
25-02-26
▲11.3%
$41.38M
−$20.71M
'25 Q1
25-05-07
▲16.3%
$51.30M
−$16.59M
'25 Q2
25-08-07
▲33.7%
$53.78M
−$11.15M
'25 Q3
25-11-05
▲45.2%
$64.62M
−$2.62M
'25 Q4
26-02-24
▲44.7%
$59.88M
−$13.38M
'26 Q1
26-05-06
LATEST
▲31.7%
$67.54M
−$11.75M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6
Revenue
$67.54M
▲ 31.7% YoY Diluted EPS
$-0.39
Gross margin
70.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Establishment Labs Holdings Inc. Q1 FY2026 Earnings Call
Confident tone
Minimally invasive platform
Safety and clinical differentiation
U.S. commercial launch momentum
Revenue
$59.88M
▲ 44.7% YoY Diluted EPS
$-0.45
Gross margin
70.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Establishment Labs Holdings Inc. Q4 FY2025 Earnings Call
Confident tone
Revenue growth and 2026 guidance
Sales force expansion and account onboarding
International and China commercial build-out
Revenue
$64.62M*
▲ 45.2% YoY Gross margin
70.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Establishment Labs Holdings Inc. Q3 FY2025 Earnings Call
Confident tone
Surgeon Training and Adoption
Product Innovation / Motiva
Preserve Minimally Invasive Procedure
Revenue
$53.78M
▲ 33.7% YoY Diluted EPS
$-0.38
Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Establishment Labs Holdings Inc. Q2 FY2025 Earnings Call
Confident tone
U.S. Revenue Growth and Market Penetration
Minimally Invasive Portfolio (Mia and Preservé)
China Underperformance and Distribution Challenges
Revenue
$51.30M
▲ 16.3% YoY Diluted EPS
$-0.57
Gross margin
68.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Establishment Labs Holdings Inc. Q1 FY2025 Earnings Call
Confident tone
U.S. launch of Motiva
Financial guidance and outlook
Mia and Preserve product launches
Revenue
$41.38M
▲ 11.3% YoY Diluted EPS
$-0.70
Gross margin
67.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Establishment Labs Holdings Inc. Q4 FY2024 Earnings Call
Confident tone
Future products Mia and Preservé
2025 financial guidance and growth
International market performance
Revenue
$44.51M*
▲ 41% YoY Gross margin
68.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Establishment Labs Holdings Inc. Q3 FY2024 Earnings Call
Confident tone
OUS revenue and China/APAC/EMEA trends
2025 financial guidance and profitability path
Macroeconomic softness in Latin America/Brazil
Revenue
$40.23M
▲ 4.5% YoY Diluted EPS
$-0.59
Gross margin
63.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Establishment Labs Holdings Inc. Q2 FY2024 Earnings Call
Confident tone
FDA approval and US launch
Revenue stabilization and growth
Mia Femtech and clinic rollout
Revenue
$44.12M
▼ 9.2% YoY Diluted EPS
$-0.62
Gross margin
65.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Establishment Labs Holdings Inc. Q1 FY2024 Earnings Call
Confident tone
U.S. Motiva approval and launch readiness
Mia Femtech expansion
China launch
Revenue
$37.17M
▼ 20.1% YoY Diluted EPS
$-0.58
Gross margin
65.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Establishment Labs Holdings Inc. Q4 FY2023 Earnings Call
Confident tone
U.S. regulatory approval and launch
China market entry
Motiva Flora tissue expander
Revenue
$31.56M*
▼ 28% YoY Gross margin
65.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Establishment Labs Holdings Inc. Q3 FY2023 Earnings Call
Revenue
$38.51M
▲ 0.7% YoY Diluted EPS
$-1.12
Gross margin
67.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Establishment Labs Holdings Inc. Q2 FY2023 Earnings Call
Revenue
$48.56M
▲ 17.9% YoY Diluted EPS
$-0.65
Gross margin
62.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Establishment Labs Holdings Inc. Q1 FY2023 Earnings Call
Revenue
$46.52M
▲ 21% YoY Diluted EPS
$-0.48
Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-27
Establishment Labs Holdings Inc. Q4 FY2022 Earnings Call
Revenue
$43.81M*
▲ 24.1% YoY Gross margin
64.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Establishment Labs Holdings Inc. Q3 FY2022 Earnings Call
Revenue
$38.24M
▲ 31.7% YoY Diluted EPS
$-0.76
Gross margin
68.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Establishment Labs Holdings Inc. Q2 FY2022 Earnings Call
Revenue
$41.19M
▲ 28.7% YoY Diluted EPS
$-1.52
Gross margin
66.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Establishment Labs Holdings Inc. Q1 FY2022 Earnings Call
Revenue
$38.45M
▲ 26.8% YoY Diluted EPS
$-0.24
Gross margin
64.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Establishment Labs Holdings Inc. Q4 FY2021 Earnings Call
Revenue
$35.31M*
▲ 31% YoY Gross margin
68.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Establishment Labs Holdings Inc. Q3 FY2021 Earnings Call
Revenue
$29.04M
▲ 27.6% YoY Diluted EPS
$-0.61
Gross margin
67.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Establishment Labs Holdings Inc. Q2 FY2021 Earnings Call
Revenue
$31.99M
▲ 205.5% YoY Diluted EPS
$-0.22
Gross margin
67.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Establishment Labs Holdings Inc. Q1 FY2021 Earnings Call
Revenue
$30.34M
▲ 23.9% YoY Diluted EPS
$-0.29
Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-09
Establishment Labs Holdings Inc. Q4 FY2020 Earnings Call
Revenue
$26.96M*
▲ 11.2% YoY Gross margin
54.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Establishment Labs Holdings Inc. Q3 FY2020 Earnings Call
Revenue
$22.76M
▼ 0.4% YoY Diluted EPS
$-0.18
Gross margin
66.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Establishment Labs Holdings Inc. Q2 FY2020 Earnings Call
Revenue
$10.47M
▼ 51.7% YoY Diluted EPS
$-0.45
Gross margin
69.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Establishment Labs Holdings Inc. Q1 FY2020 Earnings Call
Revenue
$24.48M
▲ 17.8% YoY Gross margin
63.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
Establishment Labs Holdings Inc. Q4 FY2019 Earnings Call
Revenue
$24.25M*
▲ 47.9% YoY Gross margin
67.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1688757
CUSIP
G31249108
13F (30d)
189 filings
187 filers
Visit website
Investor relations